We will turn to slide 10. As I said, my opening remarks were very pleased with the second quarter. Our operations continued to deal with manufacturing challenges, and yet production output continued to grow on a quarter-to-quarter basis, marking the sixth straight quarter of sequential volume growth. Organic volume was up 16%, and on a two-year stack, it was up 27.6%. We've made great strides at increasing our production capacity to allow for this growth. Capital headcount was up 26.1% from a year ago, and up 18.2% from the end of 2022. We continue to do a great job at onboarding new employees. We're also investing in new equipment and warehouse space that has also contributed to the increased production. Supply chain issues have begun to improve, which has helped improve output. Lead times amongst the supply chain remain lofty, but finding the supply materials has become less of a challenge. Obviously, volume growth was also a reflection of our premier sales channel. I will reiterate, our sales channel has never been as strong as it is right now, and we're now giving them more tools to help them be more successful than they've ever been. Please turn to slide 11. We're pleased to see gross margin expand in the second quarter, as we indicated on the first quarter call. As we stated on the first quarter conference call, after April 1st, we lifted the regular monthly price increase that we had in effect going back to last June. We now believe the price premium of our equipment relative to the competition is in the high single digits, down from 15% to 20% that we were at historically. This is making the value proposition of our equipment even more compelling, helping drive further share gains. At the same time, we were able to expand profit margins. Thus, we are executing our pricing strategy very well. We'll continue to monitor this closely, particularly as we approach the end of the year. It is likely that we'll continue to see cost pressures next year. We maintain that we will continue to be disciplined with pricing. For the second half of the year, we anticipate gross margin will continue to expand, but at a slower pace than what you saw in the first half. Now, let's move to slide 12. As I stated earlier, production has finally begun to outpace bookings, which we're happy to see. This has led to lower lead times, which will help us maintain competitiveness. That said, lead times are still higher than where we'd like to see them, so there's more work to be done. We are making progress, though, and we expect even more progress in the second half of the year. Overall demand remains solid. Bookings slowed in the second quarter versus the first quarter, but we do not believe this is an indication of a slowdown. Bookings at the end of last year and in the first quarter of this year were unusually strong. Supply chain issues across the construction markets seemed to have led to a pull forward by a few months that resulted in the pattern that you've seen this year. When we speak with our sales rep partners, demand in the pipeline remains strong. In fact, backlogs at most of our channel partners are at record levels, and the sentiment is very positive. Now let's turn to 13. The macro data is also still solid. Construction spending is now well beyond pre-pandemic levels, and construction starts are at strong levels. The ABI and the Dodge Momentum Index, which track the pipeline of non-residential projects early in the planning stages, also still imply the pipeline is still at historically high levels. Demand continues to be fairly broad-based for us. High center markets are very strong. The K-12 education vertical is solid. Healthcare and manufacturing are also still very good. We continue to see robust demand in the grow facility market, and while new construction of warehouses is slowed, the end market remains good for us due to retrofit work. We're also starting to see good demand from the electric vehicle and EV battery markets. There's some pockets of softness, for example, the office sector and parts of retail, but overall market demand remains solid. Turning to slide number 14. Although lead times have begun to fall, they remain higher than normal. The investments we have made in additional personnel, new equipment and warehouse space have allowed us to maintain industry best lead times, even while lead times across the industry have fallen. We will continue to invest in capacity to help us remain competitive. CapEx is expected to be up 150% this year, of which a vast majority is related to increasing production capacity. Considering that, I'm optimistic that lead times and backlog will continue to decline throughout the year. Now, let's move to slide 15. Part sales grew 14.2% in the quarter, and we're up 24.4% in the first half of the year. The business increased slightly to 5.7% of total sales, and that was in a quarter that we realized robust growth of equipment sales. We remain optimistic through the rest of the year. As the supply chain issues continue to wane, this business should benefit. Long term, we continue to anticipate this business will become a larger part of the company, both on a sales and profitability basis. Now let's turn to 16. So before finishing up handing off the call for Q&A, I want to provide some information on our outlook for the rest of the year. Based on the size and improved margin profile of the backlog and the increased production capacity and improving productivity that we anticipate, we continue to expect sales and earnings will improve sequentially in Q3. We now anticipate pricing will be a mid double digit contributor to sales growth for the next year, up from low double digits. For SG&A, as we have stated on prior calls, we are making several investments that will help position the company better for long term growth. We continue to think SG&A as a percent of sales will be higher than what we realized in '22. Finally, CapEx will be approximately $135 million. In closing, I want to finish by thanking all of our employees, sales channel partners, and customers. Thank you. We will now open up for Q&A.